{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:00:35Z","timestamp":1759960835735},"reference-count":39,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.vaccine.2004.02.013","type":"journal-article","created":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T12:37:13Z","timestamp":1078576633000},"page":"3018-3025","source":"Crossref","is-referenced-by-count":26,"title":["Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing"],"prefix":"10.1016","volume":"22","author":[{"given":"Simon","family":"Noble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"McLain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel J","family":"Dimmock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.02.013_BIB1","first-page":"105","article-title":"Influenza virus: transmission between species and relevance to emergence of the next human pandemic","volume":"13","author":"Webster","year":"1997","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.279.5349.393","article-title":"Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness","volume":"279","author":"Subbarao","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB3","unstructured":"Centers for Disease Control and Prevention. Update: isolation of avian influenza A (H5N1) viruses from humans\u2014Hong Kong, 1997\u20131998. MMWR 46;1998:1245\u20137."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0140-6736(99)03311-5","article-title":"Human infection with influenza H9N2","volume":"354","author":"Pieris","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/viro.1999.0115","article-title":"Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Hong Kong","volume":"267","author":"Guo","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0264-410X(01)00279-1","article-title":"Characterization of a human H9N2 influenza virus isolated in Hong Kong","volume":"20","author":"Saito","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3201\/eid0802.010148","article-title":"Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China, 1999","volume":"8","author":"Uyeki","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.iy.08.040190.003513","article-title":"Structural basis of immune recognition of influenza virus hemagglutinin","volume":"8","author":"Wilson","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB9","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0264-410X(99)00507-1","article-title":"Immunity to influenza in the elderly","volume":"18","author":"Webster","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB10","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/S0264-410X(02)00374-2","article-title":"Live attenuated intranasal influenza vaccine","volume":"20","author":"Belshe","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/rmv.1980020205","article-title":"Clinical and epidemiological importance of influenza viruses resistant to amantadine and rimantadine","volume":"2","author":"Hayden","year":"1992","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB12","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(99)01241-6","article-title":"Influenza","volume":"354","author":"Cox","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<135::AID-RMV276>3.0.CO;2-M","article-title":"Antiviral developments: progress with neuraminidase inhibitors","volume":"10","author":"Fiddian","year":"2000","journal-title":"Rev. Med. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2004.02.013_BIB14","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1086\/514188","article-title":"Panel summary of international pandemic influenza plans","volume":"176","author":"Cox","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB15","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1126\/science.1063817","article-title":"The origin and control of pandemic influenza","volume":"293","author":"Laver","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1471-4892(01)00085-6","article-title":"Influenza vaccines: new developments","volume":"1","author":"Rimmelzwaan","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1511\/2003.2.122","article-title":"Influenza\u2014the world is teetering on the edge of a pandemic that could kill a large fraction of the human population","volume":"91","author":"Webster","year":"2003","journal-title":"Am. Scientist"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/226325a0","article-title":"Defective viral particles and viral disease processes","volume":"226","author":"Huang","year":"1970","journal-title":"Nature (Lond.)"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-642-71272-2_2","article-title":"Defective interfering viruses and infections of animals","volume":"128","author":"Barrett","year":"1986","journal-title":"Curr. Topics Microbiol. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB20","doi-asserted-by":"crossref","unstructured":"Dimmock NJ. Antiviral activity of defective interfering influenza virus in vivo. In: Myint S, Taylor-Robinson D., editors. Viral and other infections of the respiratory tract. London: Chapman and Hall, 1996; p. 421\u2013445.","DOI":"10.1007\/978-94-011-7930-0_22"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB21","unstructured":"Lamb RA, Krug RM. Orthomyxoviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM., editors. Fields virology, vol. 1. 3rd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1996. p. 1353\u201395."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/viro.1998.9267","article-title":"Heterologous protection against a lethal human H1N1 influenza virus infection of mice by a H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung","volume":"248","author":"Duhaut","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1099\/0022-1317-67-5-839","article-title":"Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication","volume":"67","author":"Dimmock","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB24","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1099\/0022-1317-75-12-3485","article-title":"Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of type A influenza virus","volume":"75","author":"Noble","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0168-1702(93)90058-U","article-title":"Protection of three strains of mice against lethal influenza in vivo by defective interfering virus","volume":"29","author":"Morgan","year":"1993","journal-title":"Virus Res."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0042-6822(87)90463-6","article-title":"Intracellular stability of the interfering activity of a defective interfering influenza virus in the absence of virus multiplication","volume":"159","author":"Cane","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/viro.1996.0068","article-title":"Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner","volume":"216","author":"Duhaut","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1099\/0022-1317-83-2-403","article-title":"Defective segment 1 RNAs that interfere with the production of infectious influenza virus require at least 150 nucleotides of 5\u2032 sequence: evidence from a plasmid-driven system","volume":"83","author":"Duhaut","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB29","first-page":"647","article-title":"The role of antineuraminidase antibody in immunity to influenza virus infection","volume":"41","author":"Schulman","year":"1969","journal-title":"Bull. Wld. Hlth. Org."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB30","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/S0264-410X(00)00149-3","article-title":"Cross-protection against a lethal virus infection by DNA vaccine to neuraminidase","volume":"18","author":"Chen","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-0934(02)00260-4","article-title":"Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease","volume":"108","author":"Duhaut","year":"2003","journal-title":"J. Virol. Meth."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1128\/JVI.61.2.454-464.1987","article-title":"Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles","volume":"61","author":"DePolo","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.mi.27.100173.000533","article-title":"Defective interfering viruses","volume":"27","author":"Huang","year":"1973","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB36","doi-asserted-by":"crossref","unstructured":"Holland JJ, Kennedy SIT, Semler BL, Jones KL, Roux L, Grabau E. Defective interfering RNA viruses and the host cell response. In: Fraenkel-Conrat H, Wagner RR, editors. Comprehensive virology, vol. 16. New York: Plenum Press; 1980. p. 137\u201392.","DOI":"10.1007\/978-1-4613-3129-2_3"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB37","first-page":"151","article-title":"Origin and replication of defective interfering particles","volume":"93","author":"Perrault","year":"1981","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.vaccine.2004.02.013_BIB38","doi-asserted-by":"crossref","unstructured":"Nayak DP, Chambers TM, Akkina RM. Structure of defective-interfering RNAs of influenza virus and their role in interference. In: Krug RM, editor. The influenza viruses. New York: Plenum Press; 1989. p. 269\u2013317.","DOI":"10.1007\/978-1-4613-0811-9_6"},{"key":"10.1016\/j.vaccine.2004.02.013_BIB39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/rmv.1980010306","article-title":"The biological significance of defective interfering viruses","volume":"1","author":"Dimmock","year":"1991","journal-title":"Rev. Med. Virol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T14:30:10Z","timestamp":1585665010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04001586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":39,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0264410X04001586"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.02.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}